Results 261 to 270 of about 4,365,723 (297)
Some of the next articles are maybe not open access.
Death receptor‐induced cell death in prostate cancer
Journal of Cellular Biochemistry, 2003AbstractProstate cancer mortality results from metastasis and is often coupled with progression from androgen‐dependent to androgen‐independent growth. Unfortunately, no effective treatment for metastatic prostate cancer increasing patient survival is available. The absence of effective therapies reflects in part a lack of knowledge about the molecular
Natalya V, Guseva +3 more
openaire +2 more sources
Structural Studies of Death Receptors
2014This chapter describes reports of the structural characterization of death ligands and death receptors (DRs) from the tumor necrosis factor (TNF) and TNF receptor families. The review discusses the interactions of these proteins with agonist ligands, inhibitors, and downstream signaling molecules.
openaire +2 more sources
2009
The TNF receptor superfamily is a large group of membrane-associated receptors characterized by structural similarities in their extracellular and intracellular domains. A subgroup of these receptors, the so-called death receptors, shares an intracellular motif termed the death domain.
Maria Eugenia Guicciardi +1 more
openaire +1 more source
The TNF receptor superfamily is a large group of membrane-associated receptors characterized by structural similarities in their extracellular and intracellular domains. A subgroup of these receptors, the so-called death receptors, shares an intracellular motif termed the death domain.
Maria Eugenia Guicciardi +1 more
openaire +1 more source
Chemical & Engineering News Archive, 2013
Receptors for the neurotransmitter serotonin are distributed throughout nearly every organ system in the body, and they are the targets of drugs to treat innumerable problems, including depression, migraines, and obesity. Drug designers do their best to craft molecules that zero in on individual serotonin receptors (also known as 5-HTs).
openaire +1 more source
Receptors for the neurotransmitter serotonin are distributed throughout nearly every organ system in the body, and they are the targets of drugs to treat innumerable problems, including depression, migraines, and obesity. Drug designers do their best to craft molecules that zero in on individual serotonin receptors (also known as 5-HTs).
openaire +1 more source
Critical care management of chimeric antigen receptor T-cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Sandrine Valade +2 more
exaly
The Death Receptor Pathway of Apoptosis
Cold Spring Harbor Perspectives in Biology, 2022openaire +2 more sources